Hadron Therapy Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Hadron Therapy Market to 2027 - Global Analysis and Forecasts By Type ( Alpha Particle Beam, Beta Particle Beam, Carbon Ion Beam, Electron Beam, Neutron Beam, Proton Beam ); Application ( Bone and Soft Tissue Cancer, Eye Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Pediatric Cancer, Prostate Cancer, Others ); End User ( Hospitals, Clinics, Research Centers ) and Geography

Report Code: TIPRE00003804 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Hadron therapy is also called as ion beam therapy, is used to treat cancer where the fast ionizing radiations are used. These ionizing radiations are made up of charged particles or high energy photons such as protons, carbon, and other ions.
The charged photon particles penetrates the human body tissues and destroy cancerous cells with maximum energy owing to their radiobiological and physical properties such as less diffusion. Hadron therapy destroys the cancerous cells by destroying their DNA strands. It is more advanced therapy than the traditional one as it provides long-term protection against cancer, has minimal side effects, and effective against more cancer types and newborns.

MARKET DYNAMICS
The rising number of people diagnosed with cancer, rising technological advancement in cancer treatment and rising healthcare expenditure are few major factors driving the hadron therapy market. Technology advancements in oncology treatment has helped in minimizing the adverse effects of radiation therapy on healthy tissues. However there are few factors that may affect the hadron therapy market negatively which include lack awareness about hadron therapy, expensive infrastructure required for installation of hadron therapy system, limited number of hadron therapy providers, expensive treatment, lack of skilled professionals.

MARKET SCOPE
The "Global Hadron Therapy Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of hadron therapy market with detailed market segmentation by type, application, end user and geography. The global hadron therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading hadron therapy market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global hadron therapy market is segmented on the basis of type, application and end user. Based on type, the market is segmented as alpha particle beam, beta particle beam, carbon ion beam, electron beam, neutron beam and proton beam. On the basis of application, the global hadron therapy market is segmented into bone & soft tissue cancer, eye cancer, head & neck cancer, liver cancer, lung cancer, pediatric cancer, prostate cancer, and others. Based on end user, the market is segmented into hospitals, clinics and research centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hadron therapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hadron therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting hadron therapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hadron therapy market in these regions.

MARKET PLAYERS
The reports cover key developments in the hadron therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from hadron therapy market are anticipated to lucrative growth opportunities in the future with the rising demand for hadron therapy in the global market. Below mentioned is the list of few companies engaged in the hadron therapy market.

The report also includes the profiles of key hadron therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Koninklijke Philips N.V.
  • Optivus Proton Therapy, Inc.
  • Hitachi, Ltd.
  • IBA Worldwide
  • Elekta
  • Sumitomo Corporation
  • Mitsubishi Electric Corporation
  • Varian Medical Systems, Inc.
  • Mevion Medical Systems
  • ProNova Solutions, Llc.
  • ProTom International
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hadron Therapy Market - By Type
1.3.2 Hadron Therapy Market - By Application
1.3.3 Hadron Therapy Market - By End User
1.3.4 Hadron Therapy Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. HADRON THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HADRON THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HADRON THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. HADRON THERAPY - GLOBAL MARKET OVERVIEW
6.2. HADRON THERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HADRON THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ALPHA PARTICLE BEAM
7.3.1. Overview
7.3.2. Alpha Particle Beam Market Forecast and Analysis
7.4. BETA PARTICLE BEAM
7.4.1. Overview
7.4.2. Beta Particle Beam Market Forecast and Analysis
7.5. CARBON ION BEAM
7.5.1. Overview
7.5.2. Carbon Ion Beam Market Forecast and Analysis
7.6. ELECTRON BEAM
7.6.1. Overview
7.6.2. Electron Beam Market Forecast and Analysis
7.7. NEUTRON BEAM
7.7.1. Overview
7.7.2. Neutron Beam Market Forecast and Analysis
7.8. PROTON BEAM
7.8.1. Overview
7.8.2. Proton Beam Market Forecast and Analysis
8. HADRON THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BONE AND SOFT TISSUE CANCER
8.3.1. Overview
8.3.2. Bone and Soft Tissue Cancer Market Forecast and Analysis
8.4. EYE CANCER
8.4.1. Overview
8.4.2. Eye Cancer Market Forecast and Analysis
8.5. HEAD AND NECK CANCER
8.5.1. Overview
8.5.2. Head and Neck Cancer Market Forecast and Analysis
8.6. LIVER CANCER
8.6.1. Overview
8.6.2. Liver Cancer Market Forecast and Analysis
8.7. LUNG CANCER
8.7.1. Overview
8.7.2. Lung Cancer Market Forecast and Analysis
8.8. PEDIATRIC CANCER
8.8.1. Overview
8.8.2. Pediatric Cancer Market Forecast and Analysis
8.9. PROSTATE CANCER
8.9.1. Overview
8.9.2. Prostate Cancer Market Forecast and Analysis
8.10. OTHERS
8.10.1. Overview
8.10.2. Others Market Forecast and Analysis
9. HADRON THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. RESEARCH CENTERS
9.5.1. Overview
9.5.2. Research Centers Market Forecast and Analysis
10. HADRON THERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hadron Therapy Market Overview
10.1.2 North America Hadron Therapy Market Forecasts and Analysis
10.1.3 North America Hadron Therapy Market Forecasts and Analysis - By Type
10.1.4 North America Hadron Therapy Market Forecasts and Analysis - By Application
10.1.5 North America Hadron Therapy Market Forecasts and Analysis - By End User
10.1.6 North America Hadron Therapy Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hadron Therapy Market
10.1.6.1.1 United States Hadron Therapy Market by Type
10.1.6.1.2 United States Hadron Therapy Market by Application
10.1.6.1.3 United States Hadron Therapy Market by End User
10.1.6.2 Canada Hadron Therapy Market
10.1.6.2.1 Canada Hadron Therapy Market by Type
10.1.6.2.2 Canada Hadron Therapy Market by Application
10.1.6.2.3 Canada Hadron Therapy Market by End User
10.1.6.3 Mexico Hadron Therapy Market
10.1.6.3.1 Mexico Hadron Therapy Market by Type
10.1.6.3.2 Mexico Hadron Therapy Market by Application
10.1.6.3.3 Mexico Hadron Therapy Market by End User
10.2. EUROPE
10.2.1 Europe Hadron Therapy Market Overview
10.2.2 Europe Hadron Therapy Market Forecasts and Analysis
10.2.3 Europe Hadron Therapy Market Forecasts and Analysis - By Type
10.2.4 Europe Hadron Therapy Market Forecasts and Analysis - By Application
10.2.5 Europe Hadron Therapy Market Forecasts and Analysis - By End User
10.2.6 Europe Hadron Therapy Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hadron Therapy Market
10.2.6.1.1 Germany Hadron Therapy Market by Type
10.2.6.1.2 Germany Hadron Therapy Market by Application
10.2.6.1.3 Germany Hadron Therapy Market by End User
10.2.6.2 France Hadron Therapy Market
10.2.6.2.1 France Hadron Therapy Market by Type
10.2.6.2.2 France Hadron Therapy Market by Application
10.2.6.2.3 France Hadron Therapy Market by End User
10.2.6.3 Italy Hadron Therapy Market
10.2.6.3.1 Italy Hadron Therapy Market by Type
10.2.6.3.2 Italy Hadron Therapy Market by Application
10.2.6.3.3 Italy Hadron Therapy Market by End User
10.2.6.4 Spain Hadron Therapy Market
10.2.6.4.1 Spain Hadron Therapy Market by Type
10.2.6.4.2 Spain Hadron Therapy Market by Application
10.2.6.4.3 Spain Hadron Therapy Market by End User
10.2.6.5 United Kingdom Hadron Therapy Market
10.2.6.5.1 United Kingdom Hadron Therapy Market by Type
10.2.6.5.2 United Kingdom Hadron Therapy Market by Application
10.2.6.5.3 United Kingdom Hadron Therapy Market by End User
10.2.6.6 Rest of Europe Hadron Therapy Market
10.2.6.6.1 Rest of Europe Hadron Therapy Market by Type
10.2.6.6.2 Rest of Europe Hadron Therapy Market by Application
10.2.6.6.3 Rest of Europe Hadron Therapy Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hadron Therapy Market Overview
10.3.2 Asia-Pacific Hadron Therapy Market Forecasts and Analysis
10.3.3 Asia-Pacific Hadron Therapy Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Hadron Therapy Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Hadron Therapy Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Hadron Therapy Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hadron Therapy Market
10.3.6.1.1 Australia Hadron Therapy Market by Type
10.3.6.1.2 Australia Hadron Therapy Market by Application
10.3.6.1.3 Australia Hadron Therapy Market by End User
10.3.6.2 China Hadron Therapy Market
10.3.6.2.1 China Hadron Therapy Market by Type
10.3.6.2.2 China Hadron Therapy Market by Application
10.3.6.2.3 China Hadron Therapy Market by End User
10.3.6.3 India Hadron Therapy Market
10.3.6.3.1 India Hadron Therapy Market by Type
10.3.6.3.2 India Hadron Therapy Market by Application
10.3.6.3.3 India Hadron Therapy Market by End User
10.3.6.4 Japan Hadron Therapy Market
10.3.6.4.1 Japan Hadron Therapy Market by Type
10.3.6.4.2 Japan Hadron Therapy Market by Application
10.3.6.4.3 Japan Hadron Therapy Market by End User
10.3.6.5 South Korea Hadron Therapy Market
10.3.6.5.1 South Korea Hadron Therapy Market by Type
10.3.6.5.2 South Korea Hadron Therapy Market by Application
10.3.6.5.3 South Korea Hadron Therapy Market by End User
10.3.6.6 Rest of Asia-Pacific Hadron Therapy Market
10.3.6.6.1 Rest of Asia-Pacific Hadron Therapy Market by Type
10.3.6.6.2 Rest of Asia-Pacific Hadron Therapy Market by Application
10.3.6.6.3 Rest of Asia-Pacific Hadron Therapy Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hadron Therapy Market Overview
10.4.2 Middle East and Africa Hadron Therapy Market Forecasts and Analysis
10.4.3 Middle East and Africa Hadron Therapy Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Hadron Therapy Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Hadron Therapy Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Hadron Therapy Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hadron Therapy Market
10.4.6.1.1 South Africa Hadron Therapy Market by Type
10.4.6.1.2 South Africa Hadron Therapy Market by Application
10.4.6.1.3 South Africa Hadron Therapy Market by End User
10.4.6.2 Saudi Arabia Hadron Therapy Market
10.4.6.2.1 Saudi Arabia Hadron Therapy Market by Type
10.4.6.2.2 Saudi Arabia Hadron Therapy Market by Application
10.4.6.2.3 Saudi Arabia Hadron Therapy Market by End User
10.4.6.3 U.A.E Hadron Therapy Market
10.4.6.3.1 U.A.E Hadron Therapy Market by Type
10.4.6.3.2 U.A.E Hadron Therapy Market by Application
10.4.6.3.3 U.A.E Hadron Therapy Market by End User
10.4.6.4 Rest of Middle East and Africa Hadron Therapy Market
10.4.6.4.1 Rest of Middle East and Africa Hadron Therapy Market by Type
10.4.6.4.2 Rest of Middle East and Africa Hadron Therapy Market by Application
10.4.6.4.3 Rest of Middle East and Africa Hadron Therapy Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hadron Therapy Market Overview
10.5.2 South and Central America Hadron Therapy Market Forecasts and Analysis
10.5.3 South and Central America Hadron Therapy Market Forecasts and Analysis - By Type
10.5.4 South and Central America Hadron Therapy Market Forecasts and Analysis - By Application
10.5.5 South and Central America Hadron Therapy Market Forecasts and Analysis - By End User
10.5.6 South and Central America Hadron Therapy Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hadron Therapy Market
10.5.6.1.1 Brazil Hadron Therapy Market by Type
10.5.6.1.2 Brazil Hadron Therapy Market by Application
10.5.6.1.3 Brazil Hadron Therapy Market by End User
10.5.6.2 Argentina Hadron Therapy Market
10.5.6.2.1 Argentina Hadron Therapy Market by Type
10.5.6.2.2 Argentina Hadron Therapy Market by Application
10.5.6.2.3 Argentina Hadron Therapy Market by End User
10.5.6.3 Rest of South and Central America Hadron Therapy Market
10.5.6.3.1 Rest of South and Central America Hadron Therapy Market by Type
10.5.6.3.2 Rest of South and Central America Hadron Therapy Market by Application
10.5.6.3.3 Rest of South and Central America Hadron Therapy Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HADRON THERAPY MARKET, KEY COMPANY PROFILES
12.1. KONINKLIJKE PHILIPS N.V.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. OPTIVUS PROTON THERAPY, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. HITACHI, LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. IBA WORLDWIDE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELEKTA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SUMITOMO CORPORATION
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MITSUBISHI ELECTRIC CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. VARIAN MEDICAL SYSTEMS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MEVION MEDICAL SYSTEMS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PRONOVA SOLUTIONS, LLC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. PROTOM INTERNATIONAL
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Koninklijke Philips N. V.
2. Optivus Proton Therapy, Inc.
3. Hitachi, Ltd.
4. IBA Worldwide
5. Elekta
6. Sumitomo Corporation
7. Mitsubishi Electric Corporation
8. Varian Medical Systems, Inc.
9. Mevion Medical Systems
10. ProNova Solutions, Llc.
11. ProTom International
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book